Gland Pharma IPO — Listing Performance
Gland Pharma IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 9 Nov 2020 |
| Listing date | 20 Nov 2020 |
| Issue price | ₹1,500 |
| Listing-day close | ₹1,819.55 (21.3%) |
| Recent market price | ₹2,922.30 (94.82% vs issue) |
| 52-week range | ₹1,574.15 – ₹3,989.65 |
| Identifiers | NSE: GLAND · ISIN: INE068V01023 |
How the listing went
Gland Pharma had a strong market debut, ending listing day 21.3% over the issue price.
Gland Pharma against every other debut on record
- Rank in 2020: 7 of 17 NSE debuts, on a 21.3% first-day close.
- 50th percentile of 13 mainboard debuts in 2020 (median 21.3%).
- Opened 14% above issue, then added 7.3 points to the close.
- Day-one range ₹1,700 to ₹1,850: a 10% swing on the issue price.
- Last close ₹2,922.30 (11 Sep 2026): 94.82% above issue, against 21.3% on day one.
- 56% up its 52-week range of ₹1,574.15 to ₹3,989.65.
- Priced at the top of the ₹1,490 to ₹1,500 band.
- Listed 9 calendar days after close.
- All 508 mainboard debuts on record: median 12.01%, 72% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources